| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 71,005 | 58,813 | ||
| Short-term investments | 194,405 | 215,706 | ||
| Prepaid expenses and other current assets | 5,109 | 4,467 | ||
| Total current assets | 270,519 | 278,986 | ||
| Property and equipment, net | 13,484 | 14,249 | ||
| Operating lease right-of-use assets | 2,394 | 2,601 | ||
| Finance lease right-of-use assets | 33 | 45 | ||
| Restricted cash | 339 | 339 | ||
| Other non-current assets | 1,063 | 1,096 | ||
| Total assets | 287,832 | 297,316 | ||
| Accounts payable | 1,544 | 2,060 | ||
| Accrued expenses and other current liabilities | 9,424 | 9,097 | ||
| Operating lease liabilities, current | 3,073 | 3,092 | ||
| Finance lease liabilities, current | 31 | 42 | ||
| Contingent value rights liability, current | 638 | 1,149 | ||
| Total current liabilities | 14,710 | 15,440 | ||
| Operating lease liabilities, non-current | 7,097 | 7,823 | ||
| Finance lease liabilities, non-current | 7 | 9 | ||
| Contingent value rights liability, non-current | 427 | 738 | ||
| Other liabilities | 51 | 51 | ||
| Total liabilities | 22,292 | 24,061 | ||
| Additional paid-in capital | 593,454 | 580,216 | ||
| Accumulated deficit | -327,914 | -306,961 | ||
| Total stockholders' equity | 265,540 | 273,255 | ||
| Total liabilities and stockholders' equity | 287,832 | 297,316 | ||
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)